Earnings Per Share

3 Months Ended

Mar. 31, 2023

Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended March 31,
	2023		2022
Numerator:
Net (loss) income attributable to Surgery Partners, Inc.	$	(24.9)	$	12.2

Denominator:
Weighted average shares outstanding- basic	125,206		87,995
Weighted average shares outstanding- diluted (1)	125,206		90,272

(Loss) income per share:
Basic	$	(0.20)	$	0.14
Diluted (1)	$	(0.20)	$	0.14

Dilutive securities outstanding not included in the computation of (loss) income per share as their effect is antidilutive:
Stock options	1,338		1,634
Restricted shares	67		643

(1)The impact of potentially dilutive securities for the three months ended March 31, 2023, was not considered because the effect would be anti-dilutive.